Key Events This Week
28 Sep: Mojo Grade downgraded from Strong Buy to Buy amid technical softening
29 Sep: Technical momentum shifts to mildly bullish with mixed indicator signals
30 Sep: Intraday low hit at Rs.8,189.3 amid heavy put and call option activity
1 Oct: High-value trading continues despite four consecutive sessions of decline
2 Oct: No trading data available
28 September 2026: Downgrade to 'Buy' Amid Technical Softening
Apollo Hospitals began the week with a downgrade in its MarketsMOJO rating from 'Strong Buy' to 'Buy' on 28 September 2026. This adjustment was driven primarily by a moderation in technical indicators despite the company’s robust fundamentals. The stock closed at Rs.8,862.00, down 0.31% from the previous close of Rs.8,889.90, while the Sensex fell 1.60% to 34,788.97.
Fundamentally, Apollo Hospitals maintained strong operational metrics, including a return on capital employed (ROCE) of 17.13% for the latest quarter and net sales growth of 16.82% annually. The downgrade reflected mixed technical signals such as a mildly bearish weekly MACD and KST indicators, neutral RSI, and no clear volume confirmation, prompting a more cautious stance despite solid financials.
29 September 2026: Mixed Technical Momentum Amid Price Decline
The stock continued its downward trajectory, closing at Rs.8,701.90, a 1.81% decline, while the Sensex dropped 0.48% to 34,621.52. Technical momentum shifted from bullish to mildly bullish, with daily moving averages supporting short-term strength but weekly indicators like MACD and KST showing mild bearishness. The RSI remained neutral, indicating a consolidation phase.
Despite the price decline, Apollo Hospitals outperformed the Sensex’s sharper fall, reflecting resilience. The company’s Mojo Score stood at 77.0 with a Buy rating, signalling continued medium-term confidence amid short-term caution.
Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!
- - Recent Momentum qualifier
- - Stellar technical indicators
- - Large Cap fast mover
30 September 2026: Intraday Low and Heavy Options Activity Amid Price Pressure
The stock faced significant selling pressure on 30 September, closing at Rs.8,138.50, down 6.47%, and hitting an intraday low of Rs.8,189.3. This decline outpaced the hospital sector’s 3.62% fall and contrasted with the Sensex’s modest 0.17% drop. The five-day losing streak culminated in a cumulative 9.11% decline.
Despite the price weakness, Apollo Hospitals recorded one of the highest trading values of the day, with 2,09,105 shares traded worth ₹17,541.55 lakhs. Delivery volumes surged by 42.97% compared to the five-day average, indicating strong investor participation amid volatility.
Options market activity was intense, with Apollo Hospitals emerging as the most active stock in both call and put options. Call options at the ₹9,000 strike for 27 October expiry saw 4,055 contracts traded, signalling bullish bets for a potential rebound. Conversely, heavy put option volumes clustered around strikes from ₹7,400 to ₹8,500 suggested hedging and bearish positioning. Open interest surged by 31.4% to 35,483 contracts, reflecting fresh market positioning amid price declines.
Technically, the stock remained above its 200-day moving average but traded below all shorter-term averages, indicating short- to medium-term weakness despite long-term support. The mixed technical signals and heavy derivatives activity underscored a complex market sentiment.
1 October 2026: Continued Declines Despite High-Value Trading
On 1 October, Apollo Hospitals extended its losing streak to four sessions, closing at Rs.8,116.00, down 0.28%. The stock recorded a traded volume of 2,22,428 shares with a value turnover of ₹177.45 crores, ranking among the highest in the market. Delivery volumes surged dramatically by 361.08% compared to the five-day average, suggesting active repositioning by institutional investors.
Price action remained subdued with a narrow intraday range and the stock trading below all major moving averages, signalling a bearish trend. Put option activity intensified with strikes near the current price (₹8,000, ₹7,900, ₹7,800) attracting heavy volumes, indicating sustained bearish sentiment or protective hedging ahead of the 27 October expiry.
The hospital sector declined 1.59% on the day, with Apollo Hospitals underperforming its peers. The Sensex fell 0.28%, highlighting company-specific pressures amid broader market weakness.
Apollo Hospitals Enterprise Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this large-cap stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth large-cap analysis
- - Valuation assessment included
Daily Price Comparison: Apollo Hospitals vs Sensex (28 Sep - 1 Oct 2026)
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-28 | Rs.8,862.00 | -0.31% | 34,788.97 | -1.60% |
| 2026-09-29 | Rs.8,701.90 | -1.81% | 34,621.52 | -0.48% |
| 2026-09-30 | Rs.8,138.50 | -6.47% | 34,564.37 | -0.17% |
| 2026-10-01 | Rs.8,116.00 | -0.28% | 34,221.41 | -0.99% |
Key Takeaways
Positive Signals: Apollo Hospitals maintains strong fundamentals with robust ROCE above 17%, consistent revenue and profit growth, and a dominant market position in the hospital sector. Institutional investor participation remains high, as evidenced by surging delivery volumes and significant trading value. The stock’s long-term technical indicators, including a position above the 200-day moving average and a Mojo Score of 77.0 with a Buy rating, support a positive medium-term outlook.
Cautionary Signals: The week’s price decline of 8.71% significantly outpaced the Sensex’s 3.20% fall, reflecting near-term selling pressure and technical weakness. Mixed technical indicators, including mildly bearish weekly MACD and KST, neutral RSI, and trading below all short- and medium-term moving averages, suggest potential consolidation or further downside risk. Heavy put option activity clustered near current price levels indicates increased bearish sentiment or hedging, while the surge in open interest points to heightened volatility expectations ahead of the 27 October expiry.
High call option volumes at premium strikes signal some investor optimism for a rebound, creating a complex interplay of bullish and bearish positioning. The hospital sector’s own weakness adds to the challenging environment, with sectoral declines contributing to stock-specific pressures.
Conclusion
Apollo Hospitals Enterprise Ltd. faced a turbulent week marked by a significant price correction amid mixed technical signals and active derivatives market positioning. While the company’s strong fundamentals and institutional support provide a solid foundation, the recent downgrade in technical ratings and sustained selling pressure highlight the need for caution in the near term.
The stock’s underperformance relative to the Sensex and sector peers, combined with heavy put option activity and elevated open interest, suggests investors are bracing for volatility and potential downside risks. However, the presence of robust call option interest and long-term technical support indicates that a recovery remains plausible if positive catalysts emerge.
Investors should closely monitor upcoming earnings, sector developments, and technical trends to assess whether the current weakness represents a temporary correction or a more extended consolidation phase. Apollo Hospitals remains a key large-cap stock within the hospital sector, with its price action and market activity offering valuable insights into broader healthcare market sentiment.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
